Zevra Therapeutics, Inc. Common Stock Share Price
NASDAQ: ZVRAHealthcare
Live Zevra Therapeutics, Inc. Common Stock Share Price Chart
O H L
Zevra Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$10.24Low
$11.22High
Markets Today
| Previous Close | $11.32 |
|---|---|
| Open | $11.22 |
| Volume | 1,089,982 |
| Day's Range | $10.24 - $11.22 |
| 52W Range | $8.01 - $15.04 |
| Market Cap | $676.38 M |
Historical Performance
| 1M Returns | -6.06 |
|---|---|
| 3M Returns | -14.11 |
| 6M Returns | +16.46 |
| 1Y Returns | +5.89 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Zevra Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $676.38 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 11.89 |
| PEG Ratio | N/A |
| Revenue | $106.47 M |
| ROE TTM | 0.80 |
| EPS TTM | $0.96 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.11 |
| EBITDA | $-179.00 K |
| Profit Margin | 78.17 |
| Market Cap | $676.38 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 11.89 |
| PEG Ratio | N/A |
| Revenue | $106.47 M |
| ROE TTM | 0.80 |
| EPS TTM | $0.96 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.11 |
| EBITDA | $-179.00 K |
| Profit Margin | 78.17 |
Zevra Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $20.40 M | $25.88 M | $26.06 M | $34.13 M | $36.22 M | $39.66 M |
| Gross Profit + | $19.06 M | $13.50 M | $24.82 M | $32.60 M | $34.32 M | $38.14 M |
| Operating Income | -$5.36 M | -$71.04 M | $4.14 M | $9.31 M | $8.83 M | $16.78 M |
| EBITDA | -$3.71 M | -$10.68 M | $63.24 M | -$49.03 M | $9.20 M | $17.14 M |
| Interest Expense | -$1.97 M | -$2.01 M | -$2.05 M | -$1.95 M | -$1.71 M | $0 |
| Depreciation | $1.65 M | $60.36 M | $59.10 M | -$58.35 M | $368.00 K | $364.00 K |
| Income Before Tax | -$1.92 M | $76.91 M | -$977.00 K | $12.67 M | $44.80 M | $12.79 M |
| Income Tax Expense | $1.18 M | $2.20 M | -$433.00 K | $501.00 K | $6.91 M | $4.04 M |
| Net Income + | -$3.10 M | $74.71 M | -$544.00 K | $12.16 M | $37.89 M | $8.75 M |
| Net Profit Margin | -15.19% | 288.66% | -2.09% | 35.65% | 104.61% | 22.07% |
Zevra Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $6.00 K | $6.00 K | $6.00 K | $6.00 K | $6.00 K |
| Reserve & Surplus | -$508.47 M | -$436.11 M | -$436.64 M | -$422.82 M | -$385.97 M | -$377.63 M |
| Non-Current Liabilities | $104.71 M | $110.22 M | $110.84 M | $90.80 M | $25.75 M | $36.43 M |
| Current Liabilities | $26.98 M | $28.83 M | $26.11 M | $39.28 M | $47.03 M | $48.63 M |
| Total Liabilities | $131.69 M | $139.05 M | $136.95 M | $130.07 M | $72.78 M | $85.06 M |
| Fixed Assets | $67.80 M | $7.65 M | $7.22 M | $6.91 M | $6.54 M | $6.43 M |
| Current Assets | $81.57 M | $226.34 M | $225.12 M | $223.01 M | $229.97 M | $251.30 M |
| Total Assets | $172.71 M | $256.28 M | $270.12 M | $284.73 M | $278.58 M | $302.71 M |
Zevra Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$3.10 M | $74.71 M | -$544.00 K | $12.16 M | $37.89 M | $8.75 M |
| Operating Cash Flow | -$8.22 M | -$3.60 M | $4.71 M | $5.52 M | $6.14 M | $17.03 M |
| Investing Cash Flow | $10.54 M | $11.93 M | -$4.58 M | $227.00 K | $79.62 M | $31.45 M |
| Financing Cash Flow | $1.61 M | $1.38 M | $6.53 M | $2.55 M | -$52.80 M | $1.58 M |
| Change in Cash | $3.56 M | $10.37 M | $6.73 M | $7.97 M | $33.19 M | $49.73 M |
Zevra Therapeutics, Inc. Common Stock Return Calculator
The Zevra Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Zevra Therapeutics, Inc. Common Stock
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Popular Stocks
FAQs
What is the share price of Zevra Therapeutics, Inc. Common Stock today?
Zevra Therapeutics, Inc. Common Stock (ZVRA) share price as of October 13, 2026 is $10.00. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Zevra Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Zevra Therapeutics, Inc. Common Stock (ZVRA) Share by opening an international trading account with Angel One.
How can I purchase Zevra Therapeutics, Inc. Common Stock shares in India?
Purchasing Zevra Therapeutics, Inc. Common Stock (ZVRA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Zevra Therapeutics, Inc. Common Stock (ZVRA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Zevra Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Zevra Therapeutics, Inc. Common Stock (ZVRA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Zevra Therapeutics, Inc. Common Stock?
The market capitalization of Zevra Therapeutics, Inc. Common Stock on October 13, 2026, is $676.38 M.
In which sector Zevra Therapeutics, Inc. Common Stock belongs?
Zevra Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Zevra Therapeutics, Inc. Common Stock stocks?
In order to invest in Zevra Therapeutics, Inc. Common Stock (ZVRA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
